Veriheal

MAY 18, 2023

Chronic pain —a condition that affects 50.2 annually — is one of the most common reasons why medical marijuana is sought out by patients in the United States, Canada, and beyond. New guidelines for cannabis in chronic pain were recently published by a group of Canadian researchers. million people in the U.S.

Chronic Pain 98

Chronic Pain Treatment Research and Development Patients 98

United Patients Group

MARCH 15, 2023

The following are some examples of how cannabis can help patients taper off other drugs: Cannabis is a natural treatment for pain and other symptoms of withdrawal. Patients who are prescribed these medications may find that using cannabis helps them to sleep better at night and feel more relaxed during the day.

Pharmaceutical 98

Pharmaceutical Patients Chronic Pain Sleep 98

Veriheal

AUGUST 21, 2023

million in gifts in support of several causes, including the promotion of arts, Lyme and tick-borne disease research, protection of the environment, and, in this case, psychedelics research. to advance scientific research into the potential therapeutic benefits of psychedelics for mental health and well-being.

Therapy 95

Therapy Research and Development Treatment Environment 95

FloridaMarijuana.net

JUNE 12, 2018

The Epilepsy Foundation defines epilepsy as a chronic condition of the brain which causes seizures and affects 65 million people worldwide. One in 26 people will develop epilepsy in their lifetime. It is not fully known the genetic origins of epilepsy or if the condition is hereditary. appeared first on.

Epilepsy 187

Epilepsy Patients Marijuana Research and Development 187

NewsMunchies

JULY 10, 2023

Artificial intelligence is a smarter, faster, and more effective pathway to drug development. With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58

Veriheal

NOVEMBER 17, 2020

Ohio is currently accepting petitions in an attempt to expand the list of qualifying conditions for medical cannabis. But this has failed in the past and could prevent measures from moving forward this time unless new research could be presented to sway the state medical board’s decision.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

Veriheal

MARCH 18, 2021

It is quite common for cannabis researchers to make use of vertebrates since animals with spines have an endocannabinoid system (ECS), such as mice and rats. Cats do have an ECS, but why use them for research*? Unfortunately, both of these conditions result in cognitive decline and suffer from a lack of effective treatment.

CBD 107

CBD Research and Development Pets Treatment 107

United Patients Group

SEPTEMBER 7, 2023

As the perception of medical marijuana evolves and an increasing number of individuals explore its therapeutic potential, it’s crucial to develop a comprehensive understanding of cannabis’ impact on bodily systems. One area of interest and ongoing research is the relationship between cannabis and the immune system.

Research and Development 111

Research and Development Conditions Cannabinoids Patients 111

Cannabis Law Report

AUGUST 15, 2021

Aims to support acceleration of clinical development of low-dose psilocybin in SUNHA and 5MeO-DMT in other neuro-psychiatric indications. The progress Beckley Psytech has made in attracting exceptional talent to the team and advancing our ambitious clinical development programmes over the past two years has been tremendously exciting.

Medicine 98

Medicine Research and Development Conditions Treatment 98

MMJ Recs

NOVEMBER 20, 2023

These two cannabinoids represent just a fraction of the compounds within the cannabis plant, and ongoing research continues to uncover the potential of other lesser-known cannabinoids. These compounds may help reduce symptoms and improve the quality of life for patients.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. Cannabis’ Place in Substance Abuse Recovery .

Consumption 109

Consumption Patients Research and Development Data 109

United Patients Group

DECEMBER 5, 2023

It’s a topic of serious conversation, vibrant debate, and ongoing research. One area of focus is its potential for treating mental health conditions. Despite the controversy surrounding its legalization and use, there’s no denying the increasing amount of research supporting its therapeutic potential.

Research and Development 94

Research and Development Treatment Patients Conditions 94

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

JULY 13, 2021

Australia’s Victorian government says Agriculture Victoria Research scientists have developed the world’s most complete medicinal cannabis genomic reference. The organisation has been licensed by the Australian Government to undertake medicinal cannabis research. Hemp Gazette reports. Source: [link].

Medicine 105

Medicine Research and Development Agriculture Strains 105

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. The cannabis research problem. What makes a good research study, anyway?

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

AUGUST 3, 2021

Puerto Rico’s Governor has signed legislation into law protecting qualified medical cannabis patients from workplace discrimination. The legislation amends Puerto Rico’s medical marijuana access law so that registered patients are now classified as members of a protected class under the US territory’s employment protection laws.

Patients 105

Patients Law Research and Development Medicine 105

Veriheal

SEPTEMBER 18, 2020

Research Team to Study the Impact of CBD on Spinal Injury Pain. Professor Luke Henderson is set to be the study’s lead investigator and he explains that the unfortunate truth for more than half of spinal cord injury patients is the development of chronic pain. Dr. Carins is a postdoctoral researcher who completed her Ph.D.

Treatment 98

Treatment Chronic Pain Research and Development CBD 98

Veriheal

MARCH 17, 2021

Fortunately, a group of trailblazers has found a way to impede (delay or prevent) cell growth in Glioblastoma patients. The team found that a cannabinoid known as CBG is the key to impeding the growth of glioblastoma cells, in turn extending life expectancy and reducing the effects of the condition. . What is CBG?

Research and Development 109

Research and Development Treatment Cannabinoids THC 109

United Patients Group

OCTOBER 25, 2023

To address these concerns and provide clear, evidence-based answers to the most frequently asked questions about medical marijuana, we have compiled a comprehensive FAQ to help both patients and the general public make educated decisions about their healthcare options. Virgin Islands permitting its use for certain medical conditions.

Marijuana 88

Marijuana Patients Research and Development Edibles 88

CannaMD

NOVEMBER 4, 2020

According to a recent study published in the Journal of Headache Pain , across 2,032 patients and 21 illnesses, headache was a symptom treated with cannabis in 24.9% (505) of cases, while 88% (445) of headache patients treated probable migraines with cannabis. 30 percent of migraine patients in the U.S. Other Research Findings.

Patients 105

Patients Chronic Pain Marijuana Research and Development 105

Cannabis Law Report

JULY 29, 2021

Ben Kaplan, CEO of Ehave, said, “We strongly believe there is a genetic predisposition to this condition and will be conducting a large-scale genetic analysis to isolate an individuals’ risk profile. Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question.

Research and Development 105

Research and Development Conditions Data Patients 105

Cannabis Law Report

MARCH 24, 2022

Rather, it’s a modest bipartisan piece of legislation that’s simply meant to promote research into marijuana. JUST IN: The Senate passed my bill with Senators Grassley and Schatz to cut red tape around the research process of marijuana and marijuana-derived medications. — Senator Dianne Feinstein (@SenFeinstein) March 24, 2022.

Research and Development 52

Research and Development Legislation Patients Safety 52

MMJ Recs

SEPTEMBER 19, 2023

Common Causes of Chronic Pain Chronic pain is a complex and often debilitating condition, and its underlying causes can vary widely. However, several common factors contribute to the development of chronic pain. Autoimmune diseases like fibromyalgia and conditions like migraines are also frequent contributors to chronic pain.

Chronic Pain 52

Chronic Pain Patients Treatment Therapy 52

The Cannigma

FEBRUARY 2, 2021

In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Of these consumers, over half said the drug had a beneficial clinical effect on their condition. Patients can also access CBD products without a prescription through local pharmacies.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Veriheal

NOVEMBER 13, 2020

Until recently, there has been little to no research available that examines the effects of cannabis in patients diagnosed with Obsessive-Compulsive Disorder (OCD). Many patients with OCD tend to perform actions without wanting to, but feeling powerless to try and stop it. What Does Research Say About Cannabis and OCD?

Research and Development 98

Research and Development Consumption Patients Strains 98

MMJ Recs

OCTOBER 26, 2023

This guide aims to provide an in-depth exploration of medical marijuana laws in the USA, offering insights into the regulations, the legal status of medical marijuana, the differences between federal and state laws, patient rights, dispensary regulations, and much more. Patients can possess up to one ounce of usable marijuana.

Law 98

Law Marijuana Programs Dispensary 98

CannaMD

JUNE 2, 2021

As the study authors stated: The wider availability [of marijuana] means Parkinson’s patients have more of an opportunity now to experiment with it as a potential means of controlling their symptoms. However, little is known about these patients’ thoughts and experiences related to cannabis, or its perceived effect on the disease’s symptoms.

Patients 105

Patients Clinical Trials Treatment Research and Development 105

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

United Patients Group

SEPTEMBER 14, 2023

Medical cannabis has garnered tremendous attention and acceptance in recent years, with a growing body of research exploring its potential therapeutic benefits for a range of health conditions. Preliminary research also suggests it may have neuroprotective properties. To accomplish this, patients should: 1.

Terpenes 87

Terpenes Strains Research and Development Cannabinoids 87

Cannabis Law Report

AUGUST 2, 2021

42 of July 9, 2017, also known as the Act to Manage the Study, Development and Research of Cannabis for Innovation, Applicable Standards and Limits (Medicinal Cannabis Act). This amendment expands employment protections to employees who are registered and licensed medical cannabis patients. Act 15 amends Act No.

Patients 98

Patients Law Research and Development Medicine 98

Peninsula Alternative Health

MARCH 4, 2019

As pioneers of the Maryland cannabis industry, we take great pride in offering patients a wide variety of products and clinical guidance. PAH strives to be a positive influence in the community and encourages patients to use cannabis as a complimentary medicine. The patients experience at our dispensary is extremely important to us.

Patients 76

Patients Research and Development Therapy Education 76

SpeedWeed

AUGUST 16, 2021

Oxford-based startup Beckley Psytech in the United Kingdom announced August 15 that it raised $80 million to ramp up clinical trials and research using a pharmaceutical formulation of ??5-MeO-DMT From Psychedelic Toad Venom to Medical Research.

Research and Development 52

Research and Development Clinical Trials Treatment Conditions 52

MMJ Recs

FEBRUARY 27, 2024

As the state continues to navigate the complexities of legalization, patients, dispensaries, and the cannabis industry are witnessing significant changes. Dispensaries serve as the primary access point for patients seeking medical marijuana products. These cells can form tumours and interfere with normal body functions.

Dispensary 93

Dispensary Legalization Marijuana Therapy 93

LifeCannMD

FEBRUARY 1, 2024

In Florida, glaucoma is listed as a condition eligible for medical marijuana treatment. Cannabinoids and other compounds found in marijuana have been studied for their potential effects on glaucoma, a group of painful eye conditions that can lead to blindness. Research into cannabinoids and glaucoma is ongoing.

Cannabinoids 98

Cannabinoids Treatment Research and Development THC 98

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan.

Access 52

Access Patients Research and Development Treatment 52

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. This process involves various stages, including cultivation, processing, packaging, distribution, and retailing.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

SpeedWeed

JUNE 2, 2021

New Hampshire Governor Chris Sununu (R) just signed a bill to expand the list of qualifying conditions for the state’s medical marijuana program. Doctors will also be able to recommend medical pot to minors with ASD, but only if they can confirm that the patient has not responded to conventional medications or treatments.

Conditions 52

Conditions Programs Research and Development Marijuana 52